Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding

Hepatology

Volumn 52, Issue 1, 2010, Pages 230-237

  Lo, Gin Ho ^a   Chen, Wen Chi ^a   Wang, Huay Min ^a   Lee, Ching Chang ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ENTECAVIR; NADOLOL;

ADULT; ARTICLE; ASTHENIA; BLURRED VISION; BRADYCARDIA; CHILL; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIZZINESS; DRUG EFFECT; DRUG SAFETY; DYSPHAGIA; DYSPNEA; ESOPHAGUS VARICES BLEEDING; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; HYPOTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE RATE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SORE THROAT; THERAPY EFFECT; THORAX PAIN; UPPER GASTROINTESTINAL BLEEDING; VEIN LIGATION;

ADRENERGIC BETA-ANTAGONISTS; AGED; COMBINED MODALITY THERAPY; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; LIGATION; MALE; MIDDLE AGED; NADOLOL;

EID: 77954234116     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23617     Document Type: Article

References (33)

1. D'Amico G, Pagliaro L, Bosch J. The treatment of portal hypertension: a meta-analytic review. HEPATOLOGY 1995;22:332-354.
2. Pagliaro L, D'Amico G, Sorensen TIA, Lebrec D, Burroughs AK, Morabito A, et al. Prevention of first bleeding in cirrhosis. A meta-analysis of randomized trials of nonsurgical treatment. Ann Int Med 1992;117:59-70.
3. Chalasani N, Kahi C, Francois F, Pinto A, Marathe A, Bini EJ, et al. Improved patient patient survival after acute variceal bleeding: a multicenter, cohort study. Am J Gastroenterol 2003;98:653-659. (Pubitemid 36348540)
4. Teran JC, Imperiale TF, Mullen KD, Tavill AS, McCullough AJ. Primary prophylaxis of variceal bleeding in cirrhosis: a cost-effectiveness analysis. Gastroenterology 1997;112:473-482.
5. Stiegmann GV, Goff JS, Michaletz-Onody PA, Korula J, Lieberman D, Saeed ZA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992;326:1527-1532.
6. Laine L, Cook D. Endoscopic ligation compared with sclerotherapy for treatment of esophageal variceal bleeding a meta-analysis. Ann Int Med 1995;123:280-287.
7. Lo GH, Lai KH, Cheng JS, Hwu JH, Chang CF, Chen SM, et al. A prospective, randomized trial of sclerotherapy versus ligation in the management of bleeding esophageal varices. HEPATOLOGY 1995;22:466-471.
8. D'Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: an evidence-based approach. Semin Liver Dis 1999;19:475-505. (Pubitemid 30032646)
9. Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for primary prevention of variceal bleeding. N Engl J Med 1999;340:988-993.
10. Lo GH, Chen WC, Chen MH, Lin CP, Lo CC, Hsu PI, et al. Endoscopic ligation vs. nadolol in the prevention of first variceal bleeding in patients with cirrhosis. Gastrointest Endosc 2004;59:333-338.
11. Schepke M, Kleber G, Niirnberg D, Willert J, Koch L, Wilfried VS, et al. Ligation vs. propranolol for the primary prophylaxis of variceal bleeding in cirrhosis. HEPATOLOGY 2004;40:65-72.
12. Jutabha R, Jensen DM, Martin P, Savides T, Han S-H, Gornbein J. Randomized study comparing banding and propranolol to prevent initial variceal hemorrhage in cirrhotics with high risk esophageal varices. Gastroenterology 2005;128:870-881.
13. Lo GH, Liang HL, Lai KH, Chang CF, Hwu JH, Chen SM, et al. The impact of endoscopic variceal ligation on the pressure of the portal venous system. J Hepatol 1996;24:74-80.
14. Hou MC, Lin HC, Lee FY, Chang FY, Lee SD. Recurrence of esophageal varices following endoscopic treatment and its impact on rebleeding: comparison of sclerotherapy and ligation. J Hepatol 2000;32:202-208.
15. Lo GH, Lai KH, Lee SD, Tsai YT, Lo KJ. Does propranolol maintain post-sclerotherapy variceal obliteration? A prospective randomized study. J Gastroenterol Hepatol 1993;8:358-362.
16. Lo GH, Lai KH, Cheng JS, Chen MH, Huang HC, Hsu PI, et al. Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial. HEPATOLOGY 2000;32:461-465.
17. Pugh RNN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of esophagus for bleeding esophageal varices. Br J Surg 1973;60:646-649.
18. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano B, et al. Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 1981;27:213-218. (Pubitemid 12242593)
19. Imperiale TF, Chalasani N. A meta-analysis of endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleeding. HEPATOLOGY 2001;33:802-807.
20. Khuroo MS, Khuroo NS, Farahat KLC, Khuroo YS, Sofi AA, Dahab ST. Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding. Aliment Pharmacol Ther 2005;21:347-361.
21. Bosch J, Berzigotti A, Garcia-Pagan JC, Abraldes JG. The management of portal hypertension: rational basis, available treatments and future options. J Hepatol 2008;48:s68-s92.
22. Grace ND, Garcia-Pagan JC, Albillos A, Angelico M, Boyer TD, Chalasani N, et al. Prevention of the first bleeding episode. In: de Franchis R, ed. Portal hypertension. IV. Proceedings of the 4th Baveno International Consensus Workshop. London: Blackwell; 2006. p 199-200.
23. Garcia-Tsao G, Grace ND, Groszmann RJ, Conn HO, Bermann MM, Patrick MJ, et al. Short-term effects of propranolol on portal venous pressure. HEPATOLOGY 1986;6:101-106. (Pubitemid 16137851)
24. Lebrec D, Poynard T, Capron JP, Hillon P, Geoffroy P, Roulot D, et al. Nadolol for the prophylaxis of gastrointestinal bleeding in patients with cirrhosis. J Hepatol 1988;7:718-725.
25. De la Pena J, Brullet E, Sanchex-Hernandez E, Rivero M, Vergara M, Martin-Lorente JL, et al. Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial. HEPATOLOGY 2005;41:572-578.
26. Sarin SK, Wadhawan M, Agarwal SR, Tyagi P, Sharma BC. Endoscopic variceal ligation plus propranolol vs. endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol 2005;100:797-804.
27. Gheorghe C, Gheorghe L, Iacob R, Popescu I. Primary prophylaxis of variceal bleeding in cirrhotics awaiting liver transplantation. Hepatogastroenterology 2006;53:552-557. (Pubitemid 44386957)
28. Lo GH. Prevention of esophageal variceal rebleeding. J Chin Med Assoc 2006;69:553-560.
29. Lo GH, Lai KH, Cheng JS, Lin CK, Hsu PI, Chiang HT. Prophylactic banding ligation of high-risk esophageal variceal in patients with cirrhosis: a prospective, randomized trial. J Hepatol 1999;31:451-456.
30. Boyer TD. Primary prophylaxis for variceal bleeding: are we there yet? Gastroenterology 2005;128:1120-1122.
31. Tripathi D, Ferguson JW, Kochar N, Leithead JA, Therapondos G, Mcavoy N, et al. Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleeding. HEPATOLOGY 2009;50:825-833.
32. Villanueva C, Aracil C, Colomo A, Hernandez-Gea V, Lopez-Balagueer JM, Alvarez-Urturi C, et al. Acute hemodynamic response to β-blockers and prediction of long-term outcomes in primary prophylaxis of variceal bleeding. Gastroenterology 2009;137:119-128.
33. Manolakopoulos S, Triantos C, Theodoropoulos J, Vlachogiannakos J, Kougioumtzan A, Papatheodoridis G, et al. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension. J Hepatol 2009;51:468-474.